N- ( pyrazole3 -yl) -benzamide derivatives as glucokinase activators

Details for Australian Patent Application No. 2008310115 (hide)

Owner Merck Patent GmbH

Inventors Gleitz, Johannes; Emde, Ulrich; Beier, Norbert; Charon, Christine; Carniato, Denis; Burgdorf, Lars Thore

Agent Davies Collison Cave

Pub. Number AU-A-2008310115

PCT Pub. Number WO2009/046802

Priority 07019692.8 09.10.07 EP

Filing date 9 September 2008

Wipo publication date 16 April 2009

International Classifications

C07D 231/40 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

A61K 31/4155 (2006.01) - not condensed and containing further heterocyclic rings

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

3 June 2010 PCT application entered the National Phase

  PCT publication WO2009/046802 Priority application(s): WO2009/046802

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008310117-Imidazole derivatives

2008310114-Pharmaceutical compositions containing benfotiamine and one or one more pharmaceutically active agents for the treatment of pain conditions of neuropathic origin